Antioxidant Activities and Cytotoxicity of Selected Coumarin Derivatives: Preliminary Results of a Structure-Activity Relationship Study Using Computational Tools

Journal of Experimental and Clinical Medicine

Volumn 4, Issue 3, 2012, Pages 165-169

  Gacche, Rajesh N ^a   Jadhav, Sharad G ^a  

^a SWAMI RAMANAND TEERTH MARATHWADA UNIVERSITY   (India)

Author keywords

Anticancer; Antioxidant; Coumarin; In silico analysis

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; METHOTREXATE;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER CELL; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; GEOMETRY; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; IONIZATION; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 84862024864     PISSN: 18783317     EISSN: 18783325     Source Type: Journal    
DOI: 10.1016/j.jecm.2012.04.007     Document Type: Article

References (28)

1. Murray R.D.H., Mendez J., Brown S.A. The natural coumarins: occurrence, chemistry and biochemistry 1982, John Wiley, New York, p. 282-9.
2. Soine T.O. Naturally occurring coumarins and related physiological activities. J Pharm Sci 1964, 53:231.
3. Coumarins - biology, applications and mode of action 1997, 125-141. John Wiley, Chichester. R. O'Kennedy, R.D. Thornes (Eds.).
4. Paya M., Goodwin P.A., De Las Heras B., Hoult R.S. Superoxide scavenging activity in leukocytes and absence of cellular toxicity of a series of coumarins. Biochem Pharmacol 1994, 48:445-451.
5. Ojala T. Screening of plant coumarins, PhD thesis. Helsinki: University of Helsinki; 2001. p. 23-25.
6. Lacy A., O'Kennedy R. Studies on coumarins and coumarin-related compounds to determine their therapeutic role in the treatment of cancer. Current Pharma Des 2004, 10:3797-3811.
7. Borges F., Roleira F., Milhazes N., Santana L., Uriarte E. Simple coumarins and analogues in medicinal chemistry: occurrence, synthesis and biological activity. Current Med Chem 2005, 12:887-916.
8. Budzisz E., Brzezinska E., Krajewska U., Rozalski M. Cytotoxic effects, alkylating properties and molecular modelling of coumarin derivatives and their phosphonic analogues. Eur J Med Chem 2003, 38:597-603.
9. Singh R., Singh R.K., Mahdi A.A., Misra S., Rai S.P., Singh D., Cornelissen G., et al. Studies on circadian periodicity of urinary corticoids in carcinoma of the breast. In Vivo 1998, 12:69-73.
10. Singh R., Singh R.K., Mahdi A.A., Singh R.K., Kumar A., Tripathi A.K., Rai R., et al. Circadian periodicity of plasma lipid peroxides and other antioxidants as putative markers in gynaecological malignancies. In Vivo 2003, 17(6):593-600.
11. Sinha R.J., Singh R., Mehrotra S., Singh R.K. Implications of free radicals and antioxidant levels in carcinoma of the breast: a never ending battle for survival. Indian J Cancer 2009, 46(2):146-150.
12. Shih M.H., Ke F.Y. Synthesis and evaluation of antioxidant activity of sydnonyl substituted thiazolidinone and thiazoline derivatives. Bioorg Med Chem 2004, 12:4633-4643.
13. Isihara M., Yoshiko Y., Sakagami H. Quantitative structure-cytotoxicity relationship analysis of coumarin and its derivatives by semiempirical molecular orbital method. Anticancer Res 2006, 26:2883-2886.
14. Kawase M., Sakagami H., Hashimoto K., Tani S., Hauer H., Chatterjee S.S. Structure-cytotoxic activity relationships of simple hydroxylated coumarins. Anticancer Res 2003, 23:3243-3246.
15. Karelson M., Lobanov V.S. Quantum-chemical descriptors in QSAR/QSPR studies. Chem Rev 1996, 96:1027-1043.
16. Honorio K.M., Da Silva A.B.F. An AM1 study on the electron-donating and electron accepting character of biomolecules. Int J Quantum Chem 2003, 95(2):126-132.
17. Tuppurainen K., Lotjonen S., Laatikainen R., Vartiainen T., Maran U., Strandberg M., Tamm T. About the mutagenicity of chlorine-substituted furanones and halopropenals - a QSAR study using molecular orbital indexes. Mutat Res 1991, 247:97-202.
18. Pearson R.G., Songstad J. Application of the principle of hard and soft acids and bases to organic chemistry. J Amer Chem Soc 1967, 89:1827-1836.
19. Vemulapalli V., Ghilzai N.M., Jasti B.R. Physicochemical characteristics that influence the transport of drugs across intestinal barrier. AAPS Newsmagazine 2007, 18-21.
20. Wang J., Hou T., Xu X. Aqueous solubility prediction based on weighted atom type counts and solvent accessible surface areas. J Chem Inf Model 2009, 49:571-581.
21. Hoult J., Paya M. Pharmacological and biochemical actions of simple coumarins: natural products with therapeutic potential. Gen Pharmacol 1996, 27:713-722.
22. Traykova M., Kostova I. Coumarin derivatives and antioxidative stress. Int J Pharmacol 2005, 1:29-32.
23. Singh R., Singh B., Singh S., Kumar N., Arora S. Umbeliferone: an antioxidant isolated from Acacia nilotica(L.) Willd. Ex Del Food Chem 2010, 120:825-830.
24. Maucher A., von Angerer E. Antitumor activity of coumarin and 7-hydroxycoumarin against 7, 12-dimethylbenzanthracene induced rat mammary carcinomas. J Cancer Res Clin Oncol 1994, 120:502-504.
25. Chu C.Y., Tsai Y.Y., Wang C.J., Lin W.L., Tseng T.H. Induction of apoptosis by esculetin in human leukemia cells. Eur J Pharmacol 2001, 416:25-32.
26. Kawase M., Sakagami H., Motohashi N., Hauer H., Chatterjee S.S., Spengler G., Vigyikanne A.V., et al. Coumarin derivatives with tumor-specific cytotoxicity and multidrug resistance reversal activity. In Vivo 2005, 19:705-712.
27. Kobayashi S., Sameshima K., Ishii Y., Tanaka A. Toxicity of dioxins: role of absolute hardness-absolute electronegativity (η-χ diagram) as a new measure in risk assessment. Chem Pharm Bull 1995, 43:1780-1790.
28. Kobayashi S., Hamashima H., Kurihara M., Miyata N., Tanaka A. Hardness controlled enzymes and electronegativity controlled enzymes: role of an absolute hardness- electronegativity (η-χ) activity diagram as a coordinate for biological activities. Chem Pharm Bull 1998, 46:1108-1115.